SchmittR. Maker of Ritalin, psychiatric group sued. The Wall Street Journal2000 Aug 14;Sect. B19 (col 1).
2.
National Institutes of Health. NIH consensus statement. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). Bethesda, MD: US Department of Health and Human Services, 1998.
3.
Diagnostic and statistical manual of mental disorders, 4th ed.Washington, DC: American Psychiatric Association, 1994.
4.
MercuglioanoM. What is attention-deficit/hyperactivity disorder?Pediatr Clin North Am1999;46: 831–43.
5.
BarkleyR. ADHD and the nature of self-control. New York: Guilford Press, 1997.
6.
American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1997; 36 (10 suppl):85S–121S.
7.
Committee on Quality Improvement, Subcommittee on Attention-deficit/hyperactivity disorder. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics2000; 105: 1158–70.
8.
RichtersJEArnoldLEJensenPSAbikoffHConnersCKGreenhillLL. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry1995; 34: 987–1000.
9.
GreenhillLLAbikoffHBArnoldLECantwellDPConnersCKElliottG. Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry1996; 35: 1304–13.
10.
ArnoldLEAbikoffHBCantwellDPConnersCKElliottGGreenhillLL. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry1997; 54: 865–70.
11.
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry1999; 56: 1073–86.
12.
The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry1999; 56: 1088–96.
13.
SwansonJLernerMMarchJGreshamM. Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. Pediatr Clin North Am1999; 46: 993–1009.
14.
McGill-LewisJ. Psychotropics and kids. Use of drugs in treating ADHD sets off new debate about finding the right therapy for children. Drug Topics2000;(July 3):35–42.
15.
TenreiroK. Methylphenidate-placebo: A trial for attention deficit disorders. Int J Pharmaceutical Compounding2001; 5: 21–2.
16.
KentMACamfieldCSCamfieldPR. Double-blind methylphenidate trials: Practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med1999; 153: 1292–6.
17.
SprafkinJGadowKD. Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol1996; 6: 215–28.
18.
KazdinAE. Single-case research designs. Methods for clinical and applied settings. New York: Oxford University Press, 1982.
19.
MeadeV. Pharmacist with ADD helps others. J Am Pharm Assoc (Wash)1996; NS36 (8):496.